Editorial: Unravelling real‐world impact of second‐line therapies in primary biliary cholangitis—Time to change our targets? Authors' reply

LINKED CONTENT This article is linked to Gomez et al papers. To view these articles, visit https://doi.org/10.1111/apt.18004 and https://doi.org/10.1111/apt.18032

Saved in:

Bibliographic Details
Published in:	Alimentary pharmacology & therapeutics Vol. 60; no. 1; pp. 91 - 92
Main Authors:	Fernández‐Rodríguez, C. M., Gutierrez, M. L., Olveira, A.
Format:	Journal Article
Language:	English
Published:	England Wiley Subscription Services, Inc 01-07-2024
Subjects:	Cholangitis Humans Liver Cirrhosis, Biliary - drug therapy Treatment Outcome Ursodeoxycholic Acid - therapeutic use
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	LINKED CONTENT This article is linked to Gomez et al papers. To view these articles, visit https://doi.org/10.1111/apt.18004 and https://doi.org/10.1111/apt.18032
Bibliography:	SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1
ISSN:	0269-2813 1365-2036 1365-2036
DOI:	10.1111/apt.18048